Chargement en cours...

Optimized management of advanced hepatocellular carcinoma: Four long-lasting responses to sorafenib

The therapeutic options for hepatocellular carcinoma (HCC) have been so far rather inadequate. Sorafenib has shown an overall survival benefit and has become the new standard of care for advanced HCC. Nevertheless, in clinical practice, some patients are discontinuing this drug because of side effec...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Abbadessa, Giovanni, Rimassa, Lorenza, Pressiani, Tiziana, Carrillo-Infante, Cynthia, Cucchi, Emanuele, Santoro, Armando
Format: Artigo
Langue:Inglês
Publié: Baishideng Publishing Group Co., Limited 2011
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3103800/
https://ncbi.nlm.nih.gov/pubmed/21633647
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v17.i19.2450
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!